ABSTRACT
I. INTRODUCTION The assessment of outcome may address one or more aspects: lower urinary tract symptoms, influence of symptoms on quality of life, physical findings, and changes in urodynamics following treatment. There has been much confusion relative to nomenclature, and in this report the following terms are used:
LUTS: lower urinary tract symptoms. QoL: quality of life; QoL can be considered to cover bothersomeness, influence on
quality of life, and sexual functioning. BPH: benign prostatic hyperplasia; this term is reserved for the characteristic histo-
logical changes associated with BPH. BPE: benign prostatic enlargement; this term refers to documented enlargement of
the gland. BPO: benign prostatic obstruction; this term refers to obstruction documented by
urodynamic studies in the presence of an enlarged gland. BOO; bladder outlet obstruction; BOO is the generic term for obstruction.
